These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 470544)
41. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775 [TBL] [Abstract][Full Text] [Related]
42. Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo. Dorris RL Proc Soc Exp Biol Med; 1987 Oct; 186(1):13-6. PubMed ID: 3628250 [TBL] [Abstract][Full Text] [Related]
43. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. Sprah L; Zivin M; Sket D J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846 [TBL] [Abstract][Full Text] [Related]
44. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation. Korf J; Sebens JB J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979 [TBL] [Abstract][Full Text] [Related]
45. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment. Leysen JE Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770 [No Abstract] [Full Text] [Related]
46. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Gordon JH; Diamond BI Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695 [TBL] [Abstract][Full Text] [Related]
56. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Goetz CG; Klawans HL; Carvey P Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633 [No Abstract] [Full Text] [Related]
57. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. Lehmann J; Briley M; Langer SZ Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762 [TBL] [Abstract][Full Text] [Related]
58. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum. Hashimoto T; Katsura M; Kuriyama K Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302 [TBL] [Abstract][Full Text] [Related]
59. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE; Gommeren W J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046 [TBL] [Abstract][Full Text] [Related]
60. The effect of single and repeated administration of bromocriptine on monoamine metabolism in rat brain and [3H]spiroperidol binding to striatal membranes. Muradas V; Bazan E; Gervas JJ; Mena MA; de Yebenes JG Mov Disord; 1986; 1(2):103-12. PubMed ID: 3504236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]